Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human prothrombin complex for treatment of hemophilia B
CTR20202425Phase 3Completed
- Sponsor
- Lanzhou Lansheng Blood Products
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of prothrombin complex concentrate, human in hemophilia B (HB), sponsored by Lanzhou Lansheng Blood Products. Started Nov 2020; status: completed.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20202425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202425.